Abu El-Asrar, A.M.; Nawaz, M.I.; Ahmad, A.; Dillemans, L.; Siddiquei, M.; Allegaert, E.; Gikandi, P.W.; De Hertogh, G.; Opdenakker, G.; Struyf, S.
CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy. Int. J. Mol. Sci. 2023, 24, 15582.
https://doi.org/10.3390/ijms242115582
AMA Style
Abu El-Asrar AM, Nawaz MI, Ahmad A, Dillemans L, Siddiquei M, Allegaert E, Gikandi PW, De Hertogh G, Opdenakker G, Struyf S.
CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy. International Journal of Molecular Sciences. 2023; 24(21):15582.
https://doi.org/10.3390/ijms242115582
Chicago/Turabian Style
Abu El-Asrar, Ahmed M., Mohd I. Nawaz, Ajmal Ahmad, Luna Dillemans, Mairaj Siddiquei, Eef Allegaert, Priscilla W. Gikandi, Gert De Hertogh, Ghislain Opdenakker, and Sofie Struyf.
2023. "CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy" International Journal of Molecular Sciences 24, no. 21: 15582.
https://doi.org/10.3390/ijms242115582
APA Style
Abu El-Asrar, A. M., Nawaz, M. I., Ahmad, A., Dillemans, L., Siddiquei, M., Allegaert, E., Gikandi, P. W., De Hertogh, G., Opdenakker, G., & Struyf, S.
(2023). CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy. International Journal of Molecular Sciences, 24(21), 15582.
https://doi.org/10.3390/ijms242115582